An AI-Designed Vaccine Just Cleared Its First Human Trial
Key takeaways
- An AI model, not a researcher, designed the vaccine's active ingredient, and it cleared a first human trial for safety.
- It targets features shared across a whole family of coronaviruses, aiming to stay useful even as the virus mutates.
- The candidate was given needle-free, through a fine jet of fluid rather than an injection.
- Safety is not the same as protection; larger trials still have to show that it actually works.
Article deployed as HTML. See dist/article/ai-designed-vaccine-first-human-trial/index.html for full rendered copy.